Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study

10.1016/j.jtcme.2017.05.002

Mohammadreza Bordbar；Mehdi Pasalar；Sanaz Safaei；Roza kamfiroozi；Sohelia Zareifar；Omidreza zekavat；Sezaneh Haghpanah

Complementary and alternative medicine ； Thalassemia ； Hemoglobinopathy ； Traditional Persian medicine ； Iran

Journal of Traditional and Complementary Medicine

8卷1期（2018 / 01 / 01）

141 - 146

英文

This study aimed to determine the frequency and pattern of complementary and alternative medicine (CAM) use in thalassemia patients in south of Iran. The survey was done using a validated questionnaire which was distributed among 122 thalassemia patients. Only 108 questionnaires were completed and turned back (response rate 88.5%). Patients referred to an outpatient thalassemia clinic in Shiraz, southern Iran for blood transfusion. The mean age of the patients was 22.9 ± 7.9 years (range 4-45 years) with female/male ratio 1.84. Seventy four (68.5%) of the responders used CAM at least once during their life, and about half of them used it concurrently with their conventional treatments. The most reported CAM product was mint juice (50%). The most common reason of CAM use was increased general health. The most common information source about CAM was physicians who were the most trusted source as well. CAM is frequently being used in thalassemia patients to ensure their sense of well-being and help them overcome the complications of their illnesses.

1. Ameade, EPK,Amalba, A,Helegbe, GK,Mohammed, BS(2016).Medical students' knowledge and attitude towards complementary and alternative medicine - a survey in Ghana.J Tradit Complement Med,6(3),230-236.
   連結：
2. Farooqui, M,Hassali, MA,Shatar, AKA(2016).Use of complementary and alternative medicines among Malaysian cancer patients: a descriptive study.J Tradit Complement Med,6(4),321-326.
   連結：
3. Gupta, D,Batra, R,Mahajan, S(2014).Comparative evaluation of the complementary and alternative medicine therapy and conventional therapy use for musculoskeletal disorders management and its association with job satisfaction among dentists of West India.J Tradit Complement Med,4(4),263-267.
   連結：
4. Namjooyan, F,Ghanavati, R,Majdinasab, N,Jokari, S,Janbozorgi, M(2014).Uses of complementary and alternative medicine in multiple sclerosis.J Tradit Complement Med,4(3),145-152.
   連結：
5. Adams, D,Dagenais, S,Clifford, T(2013).Complementary and alternative medicine use by pediatric specialty outpatients.Pediatrics,131(2),225-232.
6. Afolabi, IS,Osikoya, IO,Fajimi, OD(2012).Solenostemon monostachyus, Ipomoea involucrata and Carica papaya seed oil versus Glutathione, or Vernonia amygdalina: methanolic extracts of novel plants for the management of sickle cell anemia disease.BMC Complement Altern Med,12,262.
7. Bahall, M.(2015).Complementary and alternative medicine usage among cardiac patients: a descriptive study.BMC Complement Altern Med,15,100.
8. Berg, EA,McGregor, JG,Burkart, ME(2014).What everybody is doing but no one is talking about: use of complementary and alternative medicine in the ANCA associated vasculitis population.J Autoimmune Dis Rheumatol,2(3),74-91.
9. Bianchi, N,Zuccato, C,Lampronti, I,Borgatti, M,Gambari, R(2009).Fetal hemoglobin inducers from the natural world: a novel approach for identification of drugs for the treatment of {beta}-thalassemia and sickle-cell anemia.Evid Based Complement Altern Med,6(2),141-151.
10. Bishop, FL,Prescott, P,Chan, YK,Saville, J,von Elm, E,Lewith, GT.(2010).Prevalence of complementary medicine use in pediatric cancer: a systematic review.Pediatrics,125(4),768-776.
11. Bordbar, MR,Silavizadeh, S,Haghpanah, S,Kamfiroozi, R,Bardestani, M,Karimi, M(2014).Hydroxyurea treatment in transfusion-dependent beta-thalassemia patients.Iran Red Crescent Med J.,16(6),e18028.
12. Efe, E,Isler, A,Sarvan, S,Baser, H,Yesilipek, A(2013).Complementary and alternative medicine use in children with thalassaemia.J Clin Nurs.,22(5-6),760-769.
13. El Sayed, SM,Abou-Taleb, A,Mahmoud, HS(2014).Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia.Med Hypotheses,83(2),238-246.
14. El Sayed, SM,Baghdadi, H,Abou-Taleb, A(2014).Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.J Blood Med,5,219-237.
15. Gambari, R,Fibach, E(2007).Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia.Curr Med Chem,14(2),199-212.
16. Gerber, LM,Mamtani, R,Chiu, YL(2014).Use of complementary and alternative medicine among midlife Arab women living in Qatar.East Mediterr Health J.,20(9),554-560.
17. Ghazeeri, GS,Awwad, JT,Alameddine, M,Younes, ZM,Naja, F(2012).Prevalence and determinants of complementary and alternative medicine use among infertile patients in Lebanon: a cross sectional study.BMC Complement Altern Med,12,129.
18. Hashempur, MH,Heydari, M,Mosavat, SH,Heydari, ST,Shams, M(2015).Complementary and alternative medicine use in Iranian patients with diabetes mellitus.J Integr Med.,13(5),319-325.
19. Khalaf, AJ,Whitford, DL(2010).The use of complementary and alternative medicine by patients with diabetes mellitus in Bahrain: a cross-sectional study.BMC Complement Altern Med,10,35.
20. Kukreja, A,Tandon, S,Mishra, A,Tiwari, A(2013).Piceatannol: a potential futuristic natural stilbene as fetal haemoglobin inducer.J Clin Diagn Res,7(12),3028.
21. Li, H,Ko, CH,Tsang, SY,Leung, PC,Fung, MC,Fung, KP(2011).The Ethanol extract of fructus trichosanthis promotes fetal hemoglobin production via p38 MAPK activation and ERK inactivation in K562 cells.Evid Based Complement Altern Med,2011,657056.
22. Macari, ER,Schaeffer, EK,West, RJ,Lowrey, CH(2013).Simvastatin and t-butylhy-droquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.Blood,121(5),830-839.
23. McConnell, BV,Applegate, M,Keniston, A,Kluger, B,Maa, EH(2014).Use of complementary and alternative medicine in an urban county hospital epilepsy clinic.Epilepsy Behav,34,73-76.
24. Oshikoya, KA,Senbanjo, IO,Njokanma, OF,Soipe, A(2008).Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria.BMC Complement Altern Med,8,66.
25. Padalia, S,Drabu, S,Raheja, I,Gupta, A,Dhamija, M(2010).Multitude potential of wheatgrass juice (Green Blood): an overview.Chron Young Sci,1(2),23.
26. Pasalar, M,Lankarani, KB(2015).Herbal medicines, a prominent component in complementary and alternative medicine use in gastrointestinal field.Am J Gastroenterol,110(6),935.
27. Pasalar, M,Lankarani, KB(2015).Considering traditional and folklore medicine in regional health systems.East Mediterr Health J.,21(5),359-360.
28. Pauline, N,Cabral, BN,Anatole, PC,Jocelyne, AM,Bruno, M,Jeanne, NY(2013).The in vitro antisickling and antioxidant effects of aqueous extracts Zanthoxyllum heitzii on sickle cell disorder.BMC Complement Altern Med,13,162.
29. Pourtsidis, A,Doganis, D,Baka, M(2015).Prayer and blessings focused for healing is the most popular complementary intervention in a paediatric oncology unit in Greece.J BUON,20(2),602-607.
30. Purwaningsih, EH,Hanani, E,Amalia, P,Krisnamurti, DGB(2011).The chelating effect of Mangifera foetida water extract on serum thalassemic patients.J Indonesian Med Assoc,61(08)
31. Rana, S,Kamboj, JK,Gandhi, V(2011).Living life the natural wayeWheatgrass and Health.Funct Foods Health Dis,1(11),444-456.
32. Roozbeh, J,Hashempur, MH,Heydari, M(2013).Use of herbal remedies among patients undergoing hemodialysis.Iran J Kidney Dis.,7(6),492-495.
33. Sibinga, EM,Shindell, DL,Casella, JF,Duggan, AK,Wilson, MH(2006).Pediatric patients with sickle cell disease: use of complementary and alternative therapies.J Altern Complement Med,12(3),291-298.
34. Thompson, WE,Eriator, I(2014).Pain control in sickle cell disease patients: use of complementary and alternative medicine.Pain Med,15(2),241-246.
35. Tonekaboni, SH,Jafari Naeini, S,Khajeh, A,Yaghini, O,Ghazavi, A,Abdollah Gorji, F(2014).Use of complementary and alternative medicine for epileptic children in tehran: a cross-sectional study (2009-2011).Iran J Child Neurol,8(1),26-31.
36. Trachtenberg, FL,Gerstenberger, E,Xu, Y(2014).Relationship among chelator adherence, change in chelators, and quality of life in thalassemia.Qual Life Res,23(8),2277-2288.
37. Valji, R,Adams, D,Dagenais, S(2013).Complementary and alternative medicine: a survey of its use in pediatric oncology.Evid Based Complement Altern Med,2013,527163.
38. Yavarian, M,Karimi, M,Bakker, E,Harteveld, CL,Giordano, PC(2004).Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.Haematologica,89(10),1172-1178.